These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1015 related articles for article (PubMed ID: 29118124)
21. Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells. Konforte D; Simard N; Paige CJ Virology; 2008 Apr; 374(1):100-13. PubMed ID: 18222514 [TBL] [Abstract][Full Text] [Related]
22. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization. Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094 [TBL] [Abstract][Full Text] [Related]
23. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. Polack A; Hörtnagel K; Pajic A; Christoph B; Baier B; Falk M; Mautner J; Geltinger C; Bornkamm GW; Kempkes B Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10411-6. PubMed ID: 8816814 [TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells. Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023 [TBL] [Abstract][Full Text] [Related]
25. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation. Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372 [TBL] [Abstract][Full Text] [Related]
26. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827 [TBL] [Abstract][Full Text] [Related]
27. Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor. Murata T; Noda C; Narita Y; Watanabe T; Yoshida M; Ashio K; Sato Y; Goshima F; Kanda T; Yoshiyama H; Tsurumi T; Kimura H J Virol; 2016 Apr; 90(8):3873-3889. PubMed ID: 26819314 [TBL] [Abstract][Full Text] [Related]
28. The Epstein-Barr Virus Regulome in Lymphoblastoid Cells. Jiang S; Zhou H; Liang J; Gerdt C; Wang C; Ke L; Schmidt SCS; Narita Y; Ma Y; Wang S; Colson T; Gewurz B; Li G; Kieff E; Zhao B Cell Host Microbe; 2017 Oct; 22(4):561-573.e4. PubMed ID: 29024646 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase. Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446 [TBL] [Abstract][Full Text] [Related]
30. EBV latent membrane protein 1 is a negative regulator of TLR9. Fathallah I; Parroche P; Gruffat H; Zannetti C; Johansson H; Yue J; Manet E; Tommasino M; Sylla BS; Hasan UA J Immunol; 2010 Dec; 185(11):6439-47. PubMed ID: 20980631 [TBL] [Abstract][Full Text] [Related]
31. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104 [TBL] [Abstract][Full Text] [Related]
32. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W mBio; 2019 Sep; 10(5):. PubMed ID: 31530670 [TBL] [Abstract][Full Text] [Related]
33. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. Chau CM; Lieberman PM J Virol; 2004 Nov; 78(22):12308-19. PubMed ID: 15507618 [TBL] [Abstract][Full Text] [Related]
34. Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site. Chen HS; Martin KA; Lu F; Lupey LN; Mueller JM; Lieberman PM; Tempera I J Virol; 2014 Feb; 88(3):1703-13. PubMed ID: 24257606 [TBL] [Abstract][Full Text] [Related]
35. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type. Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663 [TBL] [Abstract][Full Text] [Related]
36. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. Ning S; Hahn AM; Huye LE; Pagano JS J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551 [TBL] [Abstract][Full Text] [Related]
37. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines. Yoo L; Speck SH J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007 [TBL] [Abstract][Full Text] [Related]
38. MYC Controls the Epstein-Barr Virus Lytic Switch. Guo R; Jiang C; Zhang Y; Govande A; Trudeau SJ; Chen F; Fry CJ; Puri R; Wolinsky E; Schineller M; Frost TC; Gebre M; Zhao B; Giulino-Roth L; Doench JG; Teng M; Gewurz BE Mol Cell; 2020 May; 78(4):653-669.e8. PubMed ID: 32315601 [TBL] [Abstract][Full Text] [Related]
39. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells. Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904 [TBL] [Abstract][Full Text] [Related]
40. Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation. Price AM; Tourigny JP; Forte E; Salinas RE; Dave SS; Luftig MA J Virol; 2012 Oct; 86(20):11096-106. PubMed ID: 22855490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]